التفاصيل البيبلوغرافية
| العنوان: |
Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds. |
| المؤلفون: |
McCarter, Stuart J.1,2 (AUTHOR) mccarter.stuart@mayo.edu, Lesnick, Timothy G.3 (AUTHOR), Lowe, Val J.4 (AUTHOR), Rabinstein, Alejandro A.1 (AUTHOR), Przybelski, Scott A.3 (AUTHOR), Algeciras-Schimnich, Alicia5 (AUTHOR), Ramanan, Vijay K.1 (AUTHOR), Jack Jr., Clifford R.4 (AUTHOR), Petersen, Ronald C.1 (AUTHOR), Knopman, David S.1 (AUTHOR), Boeve, Bradley F.1 (AUTHOR), Kantarci, Kejal4 (AUTHOR), Vemuri, Prashanthi4 (AUTHOR), Mielke, Michelle M.1,3 (AUTHOR), Graff-Radford, Jonathan1 (AUTHOR), Jack, Clifford R4 (AUTHOR) |
| المصدر: |
Journal of Alzheimer's Disease. 2022, Vol. 87 Issue 4, p1537-1547. 11p. |
| مصطلحات موضوعية: |
*ALZHEIMER'S disease diagnosis, *PROTEINS, *AMYLOIDOSIS, *CEREBRAL hemorrhage, *NERVE tissue proteins, *CROSS-sectional method, *RESEARCH funding, *PEPTIDES |
| مستخلص: |
Background: Cerebral microbleeds (CMBs) are a common vascular pathology associated with future intracerebral hemorrhage. Plasma biomarkers of amyloid, tau, and neurodegeneration may provide a screening avenue to identify those with CMBs, but evidence is conflicting.Objective: To determine the association between plasma biomarkers (Aβ40, Aβ42, t-tau, p-tau181, p-tau217, neurofilament light chain (NfL)) and CMBs in a population-based study of aging and whether these biomarkers predict higher signal on Aβ-PET imaging in patients with multiple CMBs.Methods: 712 participants from the Mayo Clinic Study of Aging with T2* GRE MRI and plasma biomarkers were included. Biomarkers were analyzed utilizing Simoa (Aβ40, Aβ42, t-tau, NfL) or Meso Scale Discovery (p-tau181, p-tau217) platforms. Cross-sectional associations between CMBs, plasma biomarkers and Aβ-PET were evaluated using hurdle models and multivariable regression models.Results: Among the 188 (26%) individuals with≥1 CMB, a lower plasma Aβ42/Aβ40 ratio was associated with more CMBs after adjusting for covariables (IRR 568.5 95% CI 2.8-116,127). No other biomarkers were associated with risk or number CMBs. In 81 individuals with≥2 CMBs, higher plasma t-tau, p-tau181, and p-tau217 all were associated with higher Aβ-PET signal, with plasma p-tau217 having the strongest predictive value (r2 0.603, AIC -53.0).Conclusion: Lower plasma Aβ42/Aβ40 ratio and higher plasma p-tau217 were associated with brain amyloidosis in individuals with CMBs from the general population. Our results suggest that in individuals with multiple CMBs and/or lobar intracranial hemorrhage that a lower plasma Aβ42/Aβ40 ratio or elevated p-tau217 may indicate underlying cerebral amyloid angiopathy. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
